Phase 1b/2a Study Assessing the Safety and Efficacy of Felzartamab in Anti-Phospholipase A2 Receptor Autoantibody-Positive Primary Membranous Nephropathy
Related Posts
Ridker PM, Lincoff AM, Marx N, Navar AM, Sattar N, Tuttle KR, Budoff M, Böttcher M, Cavender MA, Choudhury RP, Cornel JH, Gajos G, Komuro[...]
Çolak Y, Bhatt SP, Kinney GL, Casaburi R, Nordestgaard BG, Vestbo J, Lange P, Afzal S. Development and Validation of a Pre-COPD Score to Predict[...]
Adabifirouzjaei F, Budoff M, Nomeli M. Advancements in Artificial Intelligence for Enhanced Diagnosis and Prognosis in Cardiac CT: a Comprehensive Review and Future Perspectives. Curr[...]